NCT04211402

Brief Summary

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
51mo left

Started Mar 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress60%
Mar 2020Jul 2030

First Submitted

Initial submission to the registry

December 23, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 26, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

March 2, 2020

Completed
10 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2030

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2030

Last Updated

June 5, 2025

Status Verified

June 1, 2025

Enrollment Period

10 years

First QC Date

December 23, 2019

Last Update Submit

June 2, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Correlation of Microbiome to Disease via Relative Abundance Found in Microbiome Sequencing

    Relative abundance of bacterial classes within taxonomic phyla and, more broadly, within their domain will be analyzed by sequencing the gut microbiome. These data will then be categorized with Obsessive-Compulsive Disorder

    Three years

Study Arms (1)

Obsessive-Compulsive Disorder

Patients with obsessive-compulsive disorder

Other: No Intervention

Interventions

There is no intervention for this study

Obsessive-Compulsive Disorder

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with OCD

You may qualify if:

  • Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study
  • a. May be signed by parent or legal guardian in the case of minor or adult unable to provide consent
  • Male or female of all ages
  • OCI greater than or equal to 21

You may not qualify if:

  • Refusal to sign informed consent form
  • History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
  • Postoperative stoma, ostomy, or ileoanal pouch
  • Participation in any experimental drug protocol within the past 12 weeks
  • Treatment with total parenteral nutrition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ProgenaBiome

Ventura, California, 93003, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

Stool samples

MeSH Terms

Conditions

Obsessive-Compulsive Disorder

Condition Hierarchy (Ancestors)

Anxiety DisordersMental Disorders

Study Officials

  • Sabine Hazan, MD

    ProgenaBiome

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 23, 2019

First Posted

December 26, 2019

Study Start

March 2, 2020

Primary Completion (Estimated)

March 1, 2030

Study Completion (Estimated)

July 1, 2030

Last Updated

June 5, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

There is no plan to share IPD

Locations